ISN-ISE Webinar: Obesity and Weight Management in Chronic Kidney Disease

Chronic Kidney Disease (CKD) and obesity are two leading public health issues that are becoming increasingly prevalent globally. According to the World Health Organization, more than 1.9 billion adults were overweight in 2016, and of these over 650 million were obese. Likewise, more than 800 million individuals worldwide were affected by CKD in 2017. There is a well-established link between obesity and CKD, as obesity is now identified as an independent risk factor for the development and progression of CKD. 

This webinar, jointly presented by the International Society of Nephrology and the International Society of Endocrinology, will delve into the epidemiology of obesity in the context of CKD, and the mechanisms leading to new-onset renal disease and the progression of pre-existing CKD. We will also discuss the current evidence supporting the treatment of obesity in CKD patients. Join us as we explore new pathways and treatment options, emphasizing the importance of a multidisciplinary approach in the management of obesity in CKD patients. 

Learning objectives: 

1. Describe the epidemiology of obesity in relation to CKD
2. Discuss the mechanisms of kidney injury in the setting of obesity and the role of obesity in accelerating pre-existing CKD
3. Appraise the current evidence supporting the treatment of obesity in CKD patients and its effect on disease progression
4. Discuss the treatment options for obesity in CKD patients, including lifestyle interventions, pharmacological therapies, and weight-loss surgery